Alkermes plcの将来のP / E
Alkermes plcの将来のP / Eは何ですか。
Alkermes plcの将来のP / Eは20.22です。
将来のP / Eの定義は何ですか。
未来比率P / E (株価収益率)は、企業の株価と今後12ヶ月間の1株当たり利益見込額との比率です。
The forward price to earnings ratio is similar to trailing price to earnings ratio but instead of net income uses estimated net earnings over next 12 months. Estimates are typically derived as the mean of those published by a select group of analysts with selection criteria varying. The forward price-to-earnings ratio is a powerful, but limited tool. It allows a quick snapshot of the company’s finances without getting down in the details of an accounting report.
NASDAQのセクタHealth Careにおける将来のP / Eの企業と比べるAlkermes plc
Alkermes plcは何をしますか。
alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (cns) diseases. the company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. headquartered in dublin, ireland, alkermes plc has an r&d center in waltham, massachusetts; a research and manufacturing facility in athlone, ireland; and a manufacturing facility in wilmington, ohio. for more information, please visit alkermes’ website at www.alkermes.com.
Alkermes plcと類似の将来のp / e
- Universal Health Servicesの将来のP / Eは20.20です。
- Tractor Supplyの将来のP / Eは20.20です。
- Dolby Laboratoriesの将来のP / Eは20.20です。
- RELX Plcの将来のP / Eは20.20です。
- KEC Internationalの将来のP / Eは20.20です。
- Cadila Healthcareの将来のP / Eは20.20です。
- Alkermes plcの将来のP / Eは20.22です。
- Atmosの将来のP / Eは20.23です。
- Chamberlin plcの将来のP / Eは20.24です。
- Tridentの将来のP / Eは20.24です。
- Altabancorpの将来のP / Eは20.24です。
- Ingenico SAの将来のP / Eは20.24です。
- Mastecの将来のP / Eは20.24です。